लोड हो रहा है...
Renal Cell Carcinoma With Cardiac Metastases
The median survival of metastatic renal cell carcinoma (mRCC) is 5 months with a 1-year survival rate of 29%. Cardiac metastasis from RCC is a rare finding and there is scarce data available on treatment options. Recently, the combination of nivolumab and ipilimumab has been approved as a first-line...
में बचाया:
| में प्रकाशित: | World J Oncol |
|---|---|
| मुख्य लेखकों: | , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Elmer Press
2021
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8297046/ https://ncbi.nlm.nih.gov/pubmed/34349857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/wjon1376 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|